ArticleEClinicalMedicine2026

Efficacy and safety of pegzilarginase in patients below 2 years of age with arginase 1 deficiency: a phase 3, open-label, multi-centre study.

Arunabha Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.